Cowen and Company’s Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 VYGG.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,067,769
Closed -$246K 845
2022
Q2
$246K Buy
1,067,769
+271,451
+34% +$127K 0.02% 192
2022
Q1
$573K Buy
+796,318
New +$590K 0.06% 141
2021
Q2
Sell
-13,500
Closed -$27K 801
2021
Q1
$27K Sell
13,500
-86,500
-87% -$234K ﹤0.01% 436
2020
Q4
$206K Buy
+100,000
New +$181K 0.02% 173

Other funds holding VYGG.WS

Cowen and Company's VYGG.WS Position: Q3 2022 in Review

Cowen and Company sold out of Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 (VYGG.WS) in Q3 2022, closing a stake of 1,067,769 shares — an estimated $246K sold.

Cowen and Company first reported a position in VYGG.WS in Q4 2020 and held it in 4 quarters. The position peaked at $573K in Q1 2022. 5 funds tracked by Wall St. Rank hold VYGG.WS as of Q3 2022.

  • Cowen and Company reported no remaining Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Cowen and Company sold 1,067,769 Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 shares in Q3 2022, an estimated $246K.
  • Cowen and Company first reported a position in Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 in Q4 2020 and held it in 4 quarters.
  • Cowen and Company's Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 position peaked at $573K in Q1 2022.
  • 5 funds tracked by Wall St. Rank held Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 as of Q3 2022.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.